Quarterly report pursuant to sections 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY)

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY) (USD $)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit during Development Stage [Member]
Balance at Dec. 31, 2012 $ 958,708 $ 2,159 $ 16,800,829 $ (15,844,280)
Balance (in shares) at Dec. 31, 2012   2,159,156    
Stock based compensation 833,895 0 833,895 0
Issuance of common stock in exchange for exercise of warrants in April 2013 ($8.00 per share) 306,666 38 306,628 0
Issuance of common stock in exchange for exercise of warrants in April 2013 ($8.00 per share) (in shares)   38,334    
Warrants issued for services rendered 24,073 0 24,073 0
Net loss (4,086,864) 0 0 (4,086,864)
Balance at Jun. 30, 2013 $ (1,963,522) $ 2,197 $ 17,965,425 $ (19,931,144)
Balance (in shares) at Jun. 30, 2013   2,197,490